Mid-Term Efficacy of Dupilumab in Children Aged  ≥ 36 Months to & lt;12 Years With Atopic Dermatitis: A Case Series

Actas Dermosifiliogr. 2024 Apr 1:S0001-7310(24)00277-1. doi: 10.1016/j.ad.2024.03.027. Online ahead of print.NO ABSTRACTPMID:38570087 | DOI:10.1016/j.ad.2024.03.027

Source: Actas Dermo-Sifiliograficas - April 3, 2024 Category: Dermatology Authors: F J Melgosa Ramos T D íaz Corpas S Mart ín Jiménez A Mateu Puchades Source Type: research